Durvalumab vs Spironolactone

Durvalumab vs Spironolactone: Overview

This comparison examines the pharmacological differences between Durvalumab and Spironolactone.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Spironolactone: Mineralocorticoid receptor antagonist.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Spironolactone — 1.4 hours.

Chemical Properties

Molecular Formula: Spironolactone — C24H32O4S.

Molecular Weight: Spironolactone — 416.5740 g/mol.

Type: Durvalumab — Antibody; Spironolactone — Small molecule.